Concepedia
Statistics
Publications
20
Citations
2.8K
H-Index
19
Active since
1993
Affiliations
Bristol-Myers Squibb (United States)(Current)
Yale University
Bristol-Myers Squibb (Germany)
Syracuse University
Ny Sin is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.
Publications per year
1993–2022
Epoxomicin, a potent and selective proteasome inhibitor, exhibits <i>in vivo</i> antiinflammatory activity
Lihao Meng, Royce Mohan, Benjamin H. Kwok et al. · Proceedings of the National Academy of Sciences · 1999 · 933 citations
Life Sciences, Biochemistry, Molecular Biology +15
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2
Ny Sin, Lihao Meng, Margaret Q. W. Wang et al. · Proceedings of the National Academy of Sciences · 1997 · 627 citations
Medicine, Oncology, Pharmacology +13
Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
Ny Sin, Kyung Bo Kim, Mikael Elofsson et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 207 citations · Full text
Life Sciences, Biochemistry, Medicinal Chemistry +14
Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Benjamin H. Kwok, Ny Sin, Craig M. Crews · PubMed · 1999 · 156 citations
Medicine, Biochemistry, Oncology +16
Orally Active Fusion Inhibitor of Respiratory Syncytial Virus
Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink et al. · Antimicrobial Agents and Chemotherapy · 2004 · 140 citations · Full text
Pharmacy, Infectious Diseases, Medicinal Chemistry +17
1–5 of 20